Generics 27

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Flavoxate manufacturers

27 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

27 products found

flavoxate

Tablets for oral solution 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19735
The company is a leading pharmaceutical manufacturer and supplier, specializing in providing high-quality medicines to semi-regulated and non-regulated markets worldwide. Based in Asia, the company is committed to delivering innovative healthcare products at competitive prices while continuously expanding its product portfolio across new therapeutic segments. With a strong network of reputable contract manufacturers globally, the company ensures compliance with stringent regulatory standards and environmental guidelines. The company's mission is to improve global health and well-being through knowledge-based products, aiming to be the preferred partner in the healthcare industry by consistently meeting high regulatory requirements.

Manufacturer usually replies in 8 days

flavoxate

Tablets 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19412
This pharmaceutical group is experiencing rapid growth, increasing its turnover from Rs. 1.5 crores in 2006 to Rs. 12 crores by 2009-2010 and aiming for Rs. 50 crores by 2015. While specific product details are not provided, the company operates across diverse therapeutic areas with a focus on both prescription medications and over-the-counter drugs. They highlight their management team's vision and dynamism, suggesting strong leadership driving their expansion within India.

Manufacturer usually replies in 51 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

This CTD dossier owner and manufacturer, established in the 1980s, operates within South Asia, specializing in the manufacture and supply of pharmaceutical products. Their offerings include tablets, capsules, eye, ear, and nasal drops, as well as oral and injectable suspensions. The company holds EU and US GMP approvals, signifying adherence to high manufacturing standards. Their production lines cater to a diverse range of therapeutic areas, with a focus on infectious diseases, pain management, and ophthalmology. The company boasts a sizable workforce and has a global reach, catering to markets across the world. They are recognized for their commitment to quality, utilizing high-grade chemicals and advanced machinery for production. The company emphasizes its track record in providing quality pharmaceutical products, underscoring its experience in the industry.

Want to see all 27 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Flavoxate:

Flavoxate is an anticholinergic with antimuscarinic effects, it is used as a medication for its muscle relaxant properties. Where it is used to treat urinary bladder spasms and other similar ailments. It is produced by manufacturers under the trade names of Urispas (Paladin, India), Genurin (Recordati, Italy), Uritac (El Saad company, Syria), Bladderon (Nippon Shinyaku, Japan), Bladuril (Chile), and Utispas (Apex Pharma, Nepal). Flavoxate was originally approved for use in the United States in 1970 and since has become popular in the global medical marketplace. Where, due to its emergence into the generic drugs space, it has seen frequent production and commercialization by flavoxate manufacturers and flavoxate suppliers. It is now often found on the pharmaceutical products for sale list of global distributors, where it is available for wholesale order at a variety of cost and price points.

Method of action of flavoxate:

Flavoxate belongs to a group of drugs which function as spasmolytic flavone derivatives and it specifically functions by relaxing the smooth muscles in the urinary tract. Although the exact mechanism of action remains elusive, it is known that flavoxate functions as a direct antagonist at muscarinic acetylcholine receptors in cholinergic innervated organs. This anticholinergic and parasympatholytic effect reduces the tonus of smooth muscle in the bladder, causing a reduction in the need to urinate and an increase in retention and subsequent volume per urination.

Form and dosage of flavoxate:

The final form and packaging are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, flavoxate typically comes in forms including tablets, film-coated tablets, and capsules. The recommended dose for adult patients for all clinical indications is 200 mg 3 times a day, taken by mouth. Special caution and subsequent dose adjustment should be taken with the elderly and young. Side effects are predominantly non-serious and include constipation, dizziness, and drowsiness. For a complete list of possible complications and additional information please refer to the manufacturers’ literature or an accredited healthcare provider.

Flavoxate on Pipelinepharma:

Currently, at the time of writing, we have found 2 verified flavoxate manufacturers and flavoxate suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in countries including Egypt and Lebanon. Each company and their pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of flavoxate and how to buy:

A cursory search online reveals an approximate wholesale cost for flavoxate to be £11.67 for 200 mg x 90 tablets. These values are indicated for the NHS in the UK. As such they are only intended to serve as a generalization of the current market conditions. Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find new qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.